-
2
-
-
0022553175
-
Twenty years of MOPP therapy for Hodgkin's lymphoma
-
Longo, I. L., Young, R. C. and Wesley, M. (1986). Twenty years of MOPP therapy for Hodgkin's lymphoma, J. Clin. Oncol., 4, 1295-1306.
-
(1986)
J. Clin. Oncol.
, vol.4
, pp. 1295-1306
-
-
Longo, I.L.1
Young, R.C.2
Wesley, M.3
-
3
-
-
0028224082
-
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma
-
Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Pichlmaier, H., Hirche, H., Pichlmayr, R., Buggisch, P., Witte, R. and the German Cancer Aid 17-1A Study Group (1994). Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma. Lancet, 343, 1177-1183.
-
(1994)
Lancet
, vol.343
, pp. 1177-1183
-
-
Riethmüller, G.1
Schneider-Gädicke, E.2
Schlimok, G.3
Schmiegel, W.4
Raab, R.5
Höffken, K.6
Gruber, R.7
Pichlmaier, H.8
Hirche, H.9
Pichlmayr, R.10
Buggisch, P.11
Witte, R.12
-
4
-
-
0025923704
-
Anti-My9-blocked ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells
-
Ro, D. C., Griffin, J. D., Belvin, M., Blättler, W. A., Lambert, J. M. and Ritz, J. (1991). Anti-My9-blocked ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells. Blood, 77, 2404-2412.
-
(1991)
Blood
, vol.77
, pp. 2404-2412
-
-
Ro, D.C.1
Griffin, J.D.2
Belvin, M.3
Blättler, W.A.4
Lambert, J.M.5
Ritz, J.6
-
5
-
-
0026409856
-
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
-
Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., Riyz, J. and Nadler, L. M. (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med., 325, 1525-1533.
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 1525-1533
-
-
Gribben, J.G.1
Freedman, A.S.2
Neuberg, D.3
Roy, D.C.4
Blake, K.W.5
Woo, S.D.6
Grossbard, M.L.7
Rabinowe, S.N.8
Coral, F.9
Freeman, G.J.10
Riyz, J.11
Nadler, L.M.12
-
6
-
-
0030161641
-
Treatment of minimal residual disease in acute myelogenous leukemia (AML): Focus on immunotherapeutic options
-
Simonsson, B. (1996). Treatment of minimal residual disease in acute myelogenous leukemia (AML): focus on immunotherapeutic options. Leukemia, 10 Suppl 2, 44-45.
-
(1996)
Leukemia
, vol.10
, Issue.2 SUPPL.
, pp. 44-45
-
-
Simonsson, B.1
-
7
-
-
0029118435
-
Active specific immunotherapy of melanoma
-
Mitchell, M. S. (1995). Active specific immunotherapy of melanoma.Br. Med. Bull., 51 (3), 631-645.
-
(1995)
Br. Med. Bull.
, vol.51
, Issue.3
, pp. 631-645
-
-
Mitchell, M.S.1
-
8
-
-
0027299732
-
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma
-
Grossbard, M. L., Gribben, J. G., Freedman, A. S., Lambert, J., Kinsella, J., Rabinowe, S., Eliseo, L., Taylor, J., Blatter, W., Epstein, C. and Nadler, L. (1993). Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma. Blood, 81, 2263-2271.
-
(1993)
Blood
, vol.81
, pp. 2263-2271
-
-
Grossbard, M.L.1
Gribben, J.G.2
Freedman, A.S.3
Lambert, J.4
Kinsella, J.5
Rabinowe, S.6
Eliseo, L.7
Taylor, J.8
Blatter, W.9
Epstein, C.10
Nadler, L.11
-
9
-
-
0030227736
-
Hodgkin's disease. Future treatment strategies: Fact or fiction
-
V. Diehl (ed.)
-
Schnell, R., Barth, S., Diehl, V. and Engert, A. (1996). Hodgkin's disease. Future treatment strategies: fact or fiction. In Baillieres Clinical Haematology, V. Diehl (ed.), pp.573-593.
-
(1996)
Baillieres Clinical Haematology
, pp. 573-593
-
-
Schnell, R.1
Barth, S.2
Diehl, V.3
Engert, A.4
-
10
-
-
0021270185
-
Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's lymphoma
-
Hsu, S. M. and Jaffe, E. S. (1984). Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's lymphoma. Am. J. Clin. Pathol., 82, 29-32.
-
(1984)
Am. J. Clin. Pathol.
, vol.82
, pp. 29-32
-
-
Hsu, S.M.1
Jaffe, E.S.2
-
11
-
-
0023635656
-
Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Sternberg cells
-
Hsu, S. M., Ho, Y. S. and Hsu, P. L. (1987). Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Sternberg cells. J. Nat. Cancer Inst., 79, 1091-1097.
-
(1987)
J. Nat. Cancer Inst.
, vol.79
, pp. 1091-1097
-
-
Hsu, S.M.1
Ho, Y.S.2
Hsu, P.L.3
-
12
-
-
0021972684
-
The expression of the Hodgkin's-disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Sternberg-Reed cells and histocytic malignancies are derived from activated lymphoid cells
-
Stein, H., Mason, D. Y., Gerdes, J., O'Conner, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R. and Lennert, K. (1985). The expression of the Hodgkin's-disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Sternberg-Reed cells and histocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-858.
-
(1985)
Blood
, vol.66
, pp. 848-858
-
-
Stein, H.1
Mason, D.Y.2
Gerdes, J.3
O'Conner, N.4
Wainscoat, J.5
Pallesen, G.6
Gatter, K.7
Falini, B.8
Delsol, G.9
Lemke, H.10
Schwarting, R.11
Lennert, K.12
-
13
-
-
0024333720
-
The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's lymphoma using fixed frozen tissue
-
Agnarsson, B. A. and Kadin, M. E. (1989). The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's lymphoma using fixed frozen tissue. Cancer, 63, 2083-2087.
-
(1989)
Cancer
, vol.63
, pp. 2083-2087
-
-
Agnarsson, B.A.1
Kadin, M.E.2
-
14
-
-
7344233628
-
Immunophenotypes of Reed-Sternberg cells: A study of 19 cases of Hodgkin's lymphoma in plastic-embedded sections
-
Casey, T. T., Olson, S. J., Cousar, J. B. and Collins, R. D. (1989). Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's lymphoma in plastic-embedded sections. Blood, 74, 5042-5046.
-
(1989)
Blood
, vol.74
, pp. 5042-5046
-
-
Casey, T.T.1
Olson, S.J.2
Cousar, J.B.3
Collins, R.D.4
-
15
-
-
0024400867
-
Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's lymphoma are probable dendritic cell malignancies
-
Kennedy, I. C., Hart, D. N. and Colls, B. M. (1989). Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's lymphoma are probable dendritic cell malignancies. Clin. Exp. Immunol., 76, 324-331.
-
(1989)
Clin. Exp. Immunol.
, vol.76
, pp. 324-331
-
-
Kennedy, I.C.1
Hart, D.N.2
Colls, B.M.3
-
16
-
-
0027453460
-
The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's lymphoma and contributes to the stimulating capacity of Hodgkin's lymphoma-derived cell lines
-
Delabie, J., Ceuppens, J. L., Vandenberghe, P., de Boer, M., Coorevits, L. and de Wolf-Peeters, C. (1993). The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's lymphoma and contributes to the stimulating capacity of Hodgkin's lymphoma-derived cell lines. Blood, 82, 2845-2852.
-
(1993)
Blood
, vol.82
, pp. 2845-2852
-
-
Delabie, J.1
Ceuppens, J.L.2
Vandenberghe, P.3
De Boer, M.4
Coorevits, L.5
De Wolf-Peeters, C.6
-
17
-
-
0027394657
-
The IL-2/IL-2 receptor system: A current overview
-
Taniguchi, T. and Minami, Y. (1993). The IL-2/IL-2 receptor system: a current overview. Cell, 73, 5-8.
-
(1993)
Cell
, vol.73
, pp. 5-8
-
-
Taniguchi, T.1
Minami, Y.2
-
18
-
-
0028205130
-
Recombinant single-chain immunotoxins against T- and B-cell leukemias
-
Kreitman, R. J. and Pastan, I. (1994). Recombinant single-chain immunotoxins against T- and B-cell leukemias. Leuk. Lymph., 13, 1-10.
-
(1994)
Leuk. Lymph.
, vol.13
, pp. 1-10
-
-
Kreitman, R.J.1
Pastan, I.2
-
19
-
-
0023128587
-
IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases
-
Strauchen, J. A. and Breakstone, B. A. (1987). IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases. Am. J. Pathol., 126, 506-512.
-
(1987)
Am. J. Pathol.
, vol.126
, pp. 506-512
-
-
Strauchen, J.A.1
Breakstone, B.A.2
-
20
-
-
0023832767
-
An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins
-
Till, M., May, R. D., Uhr, J. W., Thorpe, P. E. and Vitetta, E. S. (1988). An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins Cancer Res., 48, 1119-1123.
-
(1988)
Cancer Res.
, vol.48
, pp. 1119-1123
-
-
Till, M.1
May, R.D.2
Uhr, J.W.3
Thorpe, P.E.4
Vitetta, E.S.5
-
21
-
-
0019521012
-
Hodgkin's disease: Establishment and characterization of four in vitro cell lines
-
Diehl, V., Kirchner, H. H., Schaadt, M., Fonatsch, C., Stein, H., Gerdes, J. and Boie, C. (1981 ). Hodgkin's disease: establishment and characterization of four in vitro cell lines. J. Cancer Res. Clin. Oncol., 101, 111-124.
-
(1981)
J. Cancer Res. Clin. Oncol.
, vol.101
, pp. 111-124
-
-
Diehl, V.1
Kirchner, H.H.2
Schaadt, M.3
Fonatsch, C.4
Stein, H.5
Gerdes, J.6
Boie, C.7
-
22
-
-
0019907549
-
Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97
-
Casellas, P., Brown, J. P., Gros, O., Gros, P., Hellstrom, I., Jansen, F. K., Poncelet, P., Roncucci, R., Vidal, H. and Hellstrom, K. E. (1981). Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97. Int. J. Cancer, 30, 437-443.
-
(1981)
Int. J. Cancer
, vol.30
, pp. 437-443
-
-
Casellas, P.1
Brown, J.P.2
Gros, O.3
Gros, P.4
Hellstrom, I.5
Jansen, F.K.6
Poncelet, P.7
Roncucci, R.8
Vidal, H.9
Hellstrom, K.E.10
-
23
-
-
0025948173
-
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice
-
Engert, A., Martin, G., Amlot, P., Wijdenes, J., Diehl, V. and Thorpe, P. (1991). Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice. Int. J. Cancer, 49, 450-456.
-
(1991)
Int. J. Cancer
, vol.49
, pp. 450-456
-
-
Engert, A.1
Martin, G.2
Amlot, P.3
Wijdenes, J.4
Diehl, V.5
Thorpe, P.6
-
24
-
-
0028044582
-
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins
-
Winkler, U., Gottstein, C., Schön.,G., Kapp, U., Wolf, J., Hansmann, M. L., Bohlen, H., Thorpe, P., Diehl, V. and Engert, A. (1994). Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins Blood, 83, 466-475.
-
(1994)
Blood
, vol.83
, pp. 466-475
-
-
Winkler, U.1
Gottstein, C.2
Schön, G.3
Kapp, U.4
Wolf, J.5
Hansmann, M.L.6
Bohlen, H.7
Thorpe, P.8
Diehl, V.9
Engert, A.10
-
25
-
-
0031037004
-
A Phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma
-
Engert, A., Diehl, V., Schnell, R., Radszuhn, A., Hatwig, M. T., Drillich, S., Schön, G., Bohlen, H., Tesch, H., Hansmann, M. L., Barth, S., Schindler, J., Ghetie, V., Uhr, J. and Vitetta, E. (1997). A Phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. Blood, 89 (2), 403-410.
-
(1997)
Blood
, vol.89
, Issue.2
, pp. 403-410
-
-
Engert, A.1
Diehl, V.2
Schnell, R.3
Radszuhn, A.4
Hatwig, M.T.5
Drillich, S.6
Schön, G.7
Bohlen, H.8
Tesch, H.9
Hansmann, M.L.10
Barth, S.11
Schindler, J.12
Ghetie, V.13
Uhr, J.14
Vitetta, E.15
-
26
-
-
0026375173
-
Phase-I immunotoxin trial in patients with B-cell lymphoma
-
Vitetta, E. S., Stone, M., Amlot, P., Fay, J., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J. and Thorpe, P. (1991). Phase-I immunotoxin trial in patients with B-cell lymphoma. Cancer Res., 51, 4052-4058.
-
(1991)
Cancer Res.
, vol.51
, pp. 4052-4058
-
-
Vitetta, E.S.1
Stone, M.2
Amlot, P.3
Fay, J.4
May, R.5
Till, M.6
Newman, J.7
Clark, P.8
Collins, R.9
Cunningham, D.10
Ghetie, V.11
Uhr, J.12
Thorpe, P.13
-
27
-
-
0027374447
-
A Phase-I study of an anti-CD22-deglycosylated ricin A-chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
-
Amlot, P., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramillo, O., Thorpe, P., Uhr, J. and Vitetta, E. S. (1993). A Phase-I study of an anti-CD22-deglycosylated ricin A-chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood, 82, 2624-2633.
-
(1993)
Blood
, vol.82
, pp. 2624-2633
-
-
Amlot, P.1
Stone, M.J.2
Cunningham, D.3
Fay, J.4
Newman, J.5
Collins, R.6
May, R.7
McCarthy, M.8
Richardson, J.9
Ghetie, V.10
Ramillo, O.11
Thorpe, P.12
Uhr, J.13
Vitetta, E.S.14
-
28
-
-
0029056665
-
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A Phase-I study
-
Sausville, E. A., Headlee, D., Stetler-Stevenson, M., Jaffe, E. S., Solomon, D., Figg, W. D., Herdt, J., Kopp, W. C., Rager, H., Steinberg, S. M., Ghetie, V., Schindler, J., Uhr, J. W., Wittes, R. E. and Vitetta, E. S. (1995). Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A Phase-I study. Blood, 85, 3457-3465.
-
(1995)
Blood
, vol.85
, pp. 3457-3465
-
-
Sausville, E.A.1
Headlee, D.2
Stetler-Stevenson, M.3
Jaffe, E.S.4
Solomon, D.5
Figg, W.D.6
Herdt, J.7
Kopp, W.C.8
Rager, H.9
Steinberg, S.M.10
Ghetie, V.11
Schindler, J.12
Uhr, J.W.13
Wittes, R.E.14
Vitetta, E.S.15
-
29
-
-
9444268741
-
A Phase-I study of bolus vs. continuous infusion of the anti-CD 19 immunotoxin, IgG-HL37-dgA in patients with B cell lymphoma
-
Stone, M. J., Sausville, E. A., Fay, J. W., Headlee, D., Collins, R.H., Figg, W.D., Stetler-Stevenson, M., Jain, V., Jaffe, E.S., Solomon, D., Lush, R. M., Senderowilz, A., Ghetic, V., Schindler, J., Uhr, J. W. and Vitetta, E. S. (1996). A Phase-I study of bolus vs. continuous infusion of the anti-CD 19 immunotoxin, IgG-HL37-dgA in patients with B cell lymphoma. Blood, 88 (4), 1188-1197.
-
(1996)
Blood
, vol.88
, Issue.4
, pp. 1188-1197
-
-
Stone, M.J.1
Sausville, E.A.2
Fay, J.W.3
Headlee, D.4
Collins, R.H.5
Figg, W.D.6
Stetler-Stevenson, M.7
Jain, V.8
Jaffe, E.S.9
Solomon, D.10
Lush, R.M.11
Senderowilz, A.12
Ghetic, V.13
Schindler, J.14
Uhr, J.W.15
Vitetta, E.S.16
-
30
-
-
0027156735
-
Immunotoxins: Magic bullets or misguided missiles?
-
Vitetta, E. S., Thorpe, P. E. and Uhr, J. W. (1993). Immunotoxins: magic bullets or misguided missiles? Immunol. Today, 14, 252-259.
-
(1993)
Immunol. Today
, vol.14
, pp. 252-259
-
-
Vitetta, E.S.1
Thorpe, P.E.2
Uhr, J.W.3
-
31
-
-
0026102692
-
Rationale for clinical use of immunotoxins in cancer and autoimmune diseases
-
Byers, V. S. and Baldwin, R. W. (1991). Rationale for clinical use of immunotoxins in cancer and autoimmune diseases. Sem. Cell Biol., 2, 59-70.
-
(1991)
Sem. Cell Biol.
, vol.2
, pp. 59-70
-
-
Byers, V.S.1
Baldwin, R.W.2
-
32
-
-
0024536758
-
Humoral immune resonses to XMMCO-791-RTA immunotoxins in colorectal cancer patients
-
Durrant, L. G., Byers, V. S., Scannon, P. J., Rodvien, R., Grant, K., Robins, R. A., Marksman, R. A., and Baldwin, R. W. (1989). Humoral immune resonses to XMMCO-791-RTA immunotoxins in colorectal cancer patients. Clin. Exp. Immunol., 75, 258-264.
-
(1989)
Clin. Exp. Immunol.
, vol.75
, pp. 258-264
-
-
Durrant, L.G.1
Byers, V.S.2
Scannon, P.J.3
Rodvien, R.4
Grant, K.5
Robins, R.A.6
Marksman, R.A.7
Baldwin, R.W.8
-
33
-
-
0029665818
-
Metabolism of TAC (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding
-
Junghans, R. P. and Waldmann, T. A. (1996). Metabolism of TAC (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding. J. Exp. Med., 185, 1587-1602.
-
(1996)
J. Exp. Med.
, vol.185
, pp. 1587-1602
-
-
Junghans, R.P.1
Waldmann, T.A.2
-
34
-
-
0026806808
-
Recombinant toxins containing the variable domains of the anti-TAC monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia
-
Kreitman, R. J., Chaudhary, V. K., Kozak, R. W., FitzGerald, D. J. P., Waldmann, T. A. and Pastan, I. (1992). Recombinant toxins containing the variable domains of the anti-TAC monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia. Blood, 80, 2344-2352.
-
(1992)
Blood
, vol.80
, pp. 2344-2352
-
-
Kreitman, R.J.1
Chaudhary, V.K.2
Kozak, R.W.3
FitzGerald, D.J.P.4
Waldmann, T.A.5
Pastan, I.6
-
35
-
-
0027223468
-
Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or Diphteria toxin toward lymphocytes from patients with adult T-cell leukemia
-
Kreitman, R. J., Chaudhary, V. K., Waldmann, T. A., Hanchard, B., Cranston, B., FitzGerald, D. J. P. and Pastan, I. (1993). Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or Diphteria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia, 7, 553-562.
-
(1993)
Leukemia
, vol.7
, pp. 553-562
-
-
Kreitman, R.J.1
Chaudhary, V.K.2
Waldmann, T.A.3
Hanchard, B.4
Cranston, B.5
FitzGerald, D.J.P.6
Pastan, I.7
-
36
-
-
0028017569
-
486IL-2 in advanced mycosis fungoides and the Sezary syndrome: Correlation of activity and interleukin-2 receptor expression in a Phase-II study
-
486IL-2 in advanced mycosis fungoides and the Sezary syndrome: Correlation of activity and interleukin-2 receptor expression in a Phase-II study. Blood, 84, 1765-1774.
-
(1994)
Blood
, vol.84
, pp. 1765-1774
-
-
Foss, F.M.1
Borkowski, T.A.2
Gilliom, M.3
Stetler-Stevenson, M.A.4
Jaffe, E.S.5
Figg, W.D.6
Tompkins, A.7
Bastian, A.8
Nyten, P.9
Woodworth, T.10
Udey, M.C.11
Sausville, E.A.12
-
37
-
-
0009182098
-
Phase-I/II trial of DAB389IL-2 in patients with NHL, HL and CTCL
-
Foss, F. M., Nichols, J., Parker, K. and the Seragen Lymphoma Study Group. Phase-I/II trial of DAB389IL-2 in patients with NHL, HL and CTCL. (1995). Fourth International Symposium on Immunotoxins 159A.
-
(1995)
Fourth International Symposium on Immunotoxins 159A
-
-
Foss, F.M.1
Nichols, J.2
Parker, K.3
-
38
-
-
0023529699
-
Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein
-
Williams, D. P., Parker, K., Bacha, P., Bishai. W., Borowksi, M., Genbauffe, F., Strom, T. B. and Murphy, J. R. (1987). Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Prot Eng, 1. 493-498.
-
(1987)
Prot Eng
, vol.1
, pp. 493-498
-
-
Williams, D.P.1
Parker, K.2
Bacha, P.3
Bishai, W.4
Borowksi, M.5
Genbauffe, F.6
Strom, T.B.7
Murphy, J.R.8
-
39
-
-
0027292385
-
Phase-I trial of a 90-minute infusion of the fusion toxin DAB4861L-2 in hematological cancers
-
LeMaistre, C. F., Craig, F. E., Meneghetti, C. M., McMullin, B., Parker, K., Reuben, J., Boldt, D. H., Rosenblum, M. and Woodworth, T. (1993). Phase-I trial of a 90-minute infusion of the fusion toxin DAB4861L-2 in hematological cancers Cancer Res, 53, 3930-3934.
-
(1993)
Cancer Res
, vol.53
, pp. 3930-3934
-
-
LeMaistre, C.F.1
Craig, F.E.2
Meneghetti, C.M.3
McMullin, B.4
Parker, K.5
Reuben, J.6
Boldt, D.H.7
Rosenblum, M.8
Woodworth, T.9
-
40
-
-
0026628118
-
486IL-2) in hematologic malignancies expressing the IL-2 receptor
-
486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood, 79, 2547-2554.
-
(1992)
Blood
, vol.79
, pp. 2547-2554
-
-
LeMaistre, C.F.1
Meneghetti, C.2
Rosenblum, M.3
Reuben, J.4
Parker, K.5
Shaw, J.6
Deisseroth, A.7
Woodworth, T.8
Parkinson, D.R.9
-
41
-
-
0028009151
-
486,IL-2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy
-
486,IL-2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy. Cancer, 73, 1276-1285.
-
(1994)
Cancer
, vol.73
, pp. 1276-1285
-
-
Tepler, I.1
Schwartz, G.2
Parker, K.3
Charette, J.4
Kadin, M.E.5
Woodworth, T.G.6
Schnipper, L.E.7
-
42
-
-
0019981972
-
Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's lymphoma and a subset of normal lymphoid cells
-
Schwab, U., Stein, H., Gerdes, J., Kirchner, H., Schaadt, M. and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's lymphoma and a subset of normal lymphoid cells. Nature, 299, 65-67.
-
(1982)
Nature
, vol.299
, pp. 65-67
-
-
Schwab, U.1
Stein, H.2
Gerdes, J.3
Kirchner, H.4
Schaadt, M.5
Diehl, V.6
-
43
-
-
0026643025
-
+ lymphoma: in vitro evaluation
-
+ lymphoma: in vitro evaluation. Br. J. Haematol., 81, 203-211.
-
(1992)
Br. J. Haematol.
, vol.81
, pp. 203-211
-
-
Tazzari, P.L.1
Bolognesi, A.2
De Totero, D.3
Falini, B.4
Lemoli, R.M.5
Soria, M.R.6
Pileri, S.7
Gobbi, M.8
Stein, H.9
Flenghi, L.10
Martelli, M.F.11
Stirpe, F.12
-
44
-
-
0028926611
-
+ anaplastic large-cell lymphoma
-
+ anaplastic large-cell lymphoma. Blood, 85, 2139-2146.
-
(1995)
Blood
, vol.85
, pp. 2139-2146
-
-
Pasqualucci, L.1
Wasik, M.2
Teicher, B.A.3
Flenghi, L.4
Bolognesi, A.5
Stirpe, F.6
Polito, L.7
Falini, B.8
Kadin, M.E.9
-
45
-
-
0026587530
-
Response of refractory Hodgkin's lymphoma to monoclonal anti-CD30 immunotoxin
-
Falini, B., Bolognesi, A., Flenghi, L., Tazzari, P. L., Broe, M. K., Stein, H. and Dürkop, H. (1992). Response of refractory Hodgkin's lymphoma to monoclonal anti-CD30 immunotoxin. Lancet, 339, 1195-1196.
-
(1992)
Lancet
, vol.339
, pp. 1195-1196
-
-
Falini, B.1
Bolognesi, A.2
Flenghi, L.3
Tazzari, P.L.4
Broe, M.K.5
Stein, H.6
Dürkop, H.7
-
46
-
-
0003002141
-
Anti-CD30 immunotoxins: Experimental and clinical studies
-
Falini, B., Pasqualucci, L., Flenghi, L., Bolognesi, A., Kadin, M., Stein, H., Martinelli, M. F. and Stirpe, F. Anti-CD30 immunotoxins: experimental and clinical studies. Abstracts of the Fourth International Symposium on Immunotoxins 1995, 160.
-
(1995)
Abstracts of the Fourth International Symposium on Immunotoxins
, vol.160
-
-
Falini, B.1
Pasqualucci, L.2
Flenghi, L.3
Bolognesi, A.4
Kadin, M.5
Stein, H.6
Martinelli, M.F.7
Stirpe, F.8
-
47
-
-
0025122427
-
Evaluation of ricin A-chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's lymphoma
-
Engert, A., Burrows, F., Jung, W., Tazzari, P. L., Stein, H., Pfreundschuh, M., Diehl, V. and Thorpe, P. (1990). Evaluation of ricin A-chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's lymphoma. Cancer Res., 50, 84-88.
-
(1990)
Cancer Res.
, vol.50
, pp. 84-88
-
-
Engert, A.1
Burrows, F.2
Jung, W.3
Tazzari, P.L.4
Stein, H.5
Pfreundschuh, M.6
Diehl, V.7
Thorpe, P.8
-
48
-
-
0025328975
-
Antitumor effects of ricin A-chain immunotoxins prepared from intact antibodies and Fab′ fragments on solid human Hodgkin's lymphoma tumors in mice
-
Engert, A., Martin, G., Pfreundschuh, M., Amlot, P., Hsu, S. M., Diehl, V. and Thorpe, P. E. (1990). Antitumor effects of ricin A-chain immunotoxins prepared from intact antibodies and Fab′ fragments on solid human Hodgkin's lymphoma tumors in mice. Cancer Res., 50, 2929-2935.
-
(1990)
Cancer Res.
, vol.50
, pp. 2929-2935
-
-
Engert, A.1
Martin, G.2
Pfreundschuh, M.3
Amlot, P.4
Hsu, S.M.5
Diehl, V.6
Thorpe, P.E.7
-
49
-
-
0028908960
-
Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4)
-
Horn-Lohrens, O., Tiemann, M., Lange, H., Koharg, J., Hafner, M., Hansen, H., Sterry, W., Parwaresch, R. M. and Lemke, H. (1995). Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). In. J. Cancer, 60, 539-544.
-
(1995)
In. J. Cancer
, vol.60
, pp. 539-544
-
-
Horn-Lohrens, O.1
Tiemann, M.2
Lange, H.3
Koharg, J.4
Hafner, M.5
Hansen, H.6
Sterry, W.7
Parwaresch, R.M.8
Lemke, H.9
-
50
-
-
0028828078
-
Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen
-
Schnell, R., Linnartz, C., Schön, G., Katouzi, A., Bohlen, H., Horn-Lohrens, O., Parwaresch, R., Diehl, V., Lemke, H. and Engert, A. (1995). Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. Int. J. Cancer, 63, 238-244.
-
(1995)
Int. J. Cancer
, vol.63
, pp. 238-244
-
-
Schnell, R.1
Linnartz, C.2
Schön, G.3
Katouzi, A.4
Bohlen, H.5
Horn-Lohrens, O.6
Parwaresch, R.7
Diehl, V.8
Lemke, H.9
Engert, A.10
-
51
-
-
0028866012
-
Cocktails of ricin A-chain immunotoxins against different antigens of Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice
-
Engert, A., Gottstein, C., Bohlen, H., Winkler, U., Schön. G., Manske, O., Schnell, R., Diehl, V. and Thorpe, P. (1995). Cocktails of ricin A-chain immunotoxins against different antigens of Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice. Int. J. Cancer, 63, 304-309.
-
(1995)
Int. J. Cancer
, vol.63
, pp. 304-309
-
-
Engert, A.1
Gottstein, C.2
Bohlen, H.3
Winkler, U.4
Schön, G.5
Manske, O.6
Schnell, R.7
Diehl, V.8
Thorpe, P.9
-
52
-
-
0023632524
-
Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins
-
Katz, F. E., Janossy, G., Cumber, A., Ross, W., Blacklock, H. A., Tax, W. and Thorpe, P. E. (1987). Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins. Brit. J. Haemalot., 67, 407-411.
-
(1987)
Brit. J. Haemalot.
, vol.67
, pp. 407-411
-
-
Katz, F.E.1
Janossy, G.2
Cumber, A.3
Ross, W.4
Blacklock, H.A.5
Tax, W.6
Thorpe, P.E.7
-
53
-
-
0026803031
-
The antitumor activity of an anti-CD 22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD 19 antibody or an anti-CD 19 immunotoxin
-
Ghetie, M. A., Tucker, K., Richardson, J., Uhr, J. W. and Vitetta, E. S. (1992). The antitumor activity of an anti-CD 22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD 19 antibody or an anti-CD 19 immunotoxin. Blood, 80, 2315-2320.
-
(1992)
Blood
, vol.80
, pp. 2315-2320
-
-
Ghetie, M.A.1
Tucker, K.2
Richardson, J.3
Uhr, J.W.4
Vitetta, E.S.5
|